On one end of the spectrum, increase in PRS-I activity results in PRS-I superactivity with its defining characteristic of childhood gout and variable symptoms of sensorineural hearing loss, hypotonia, and ataxia depending on the severity of the mutation. Here, PRPS1 is linked to Ataxia.